Market Place
Sourcing Support
Pfizer`s chief scientist Mikael Dolsten to step down
09 Jul 2024 //
REUTERS
HHS asks Supreme Court to reject Pfizer`s anti-kickback appeal
15 Dec 2022 //
FIERCEPHARMA
Pfizer gains powerful allies in its Vyndaqel copay case
15 Nov 2022 //
FIERCEPHARMA
Pfizer petitions Supreme Court over anti-kickback case
18 Oct 2022 //
ENDPTS
Pfizer’s VYNDAQEL/VYNDAMAX Reduced the Risk of All-Cause Mortality
20 Dec 2021 //
BIOSPACE
Pfizer’s VYNDAQEL/VYNDAMAX Reduces Risk of All-Cause Mortality by 41% in ATTR-CM
20 Dec 2021 //
BUSINESSWIRE
Pfizer fails in another challenge to U.S. anti-kickback policies
02 Oct 2021 //
FIERCEPHARMA
Dutch HTA Calls for Big Discount For Pfizer’s Vyndaqel
31 Aug 2021 //
PINK SHEET
Pfizer`s new Vyndaqel, Vyndamax reach blockbuster threshold
03 Feb 2021 //
FIERCE PHARMA
Pfizer`s Vyndaqel zooms toward blockbusterland, even amid COVID
06 Nov 2020 //
FIERCE PHARMA
Pfizer targets anti-kickback rules in Vyndaqel Medicare suit
30 Jun 2020 //
FIERCE PHARMA
Alnylam scores speedy FDA approval for rare liver disease
21 Nov 2019 //
FIERCE PHARMA
Pfizer`s Vyndaqel franchise, buoyed by diagnose, is poised for `a decisive beat`
19 Oct 2019 //
FIERCE PHARMA
After leadership shuffle, Akcea hands heart drug to Pfizer for $250M
08 Oct 2019 //
FIERCE BIOTECH
Alnylam`s Onpattro back in the game against Ionis, thanks to NICE U-turn
09 Jul 2019 //
FIERCE PHARMA
Approved new drug for rare disease
07 Nov 2016 //
ANVISA
Pfizer’s Vyndaqel slows neurodegenerative disease, analysis shows
10 Aug 2016 //
PHARMATIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.